The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Chemotherapy-induced peripheral neuropathic pain (CIPN) is a common and severe debilitating side effect of many widely used cytostatics. However, there is no approved pharmacological treatment for CIPN available. Among other substances, oxaliplatin causes CIPN in up to 80% of treated patients. Here, we report the involvement of the G-protein couple...
Alternative Titles
Full title
The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1e74672e0a2c4692add969dc360ea3e5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e74672e0a2c4692add969dc360ea3e5
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-017-00591-0
